Microbot Medical to Highlight LIBERTY Endovascular Robotic System at Society of Robotic Surgery Annual Meeting
Microbot Medical, a medical technology company developing and commercializing robotic solutions for minimally invasive vascular procedures, is set to participate in the Society of Robotic Surgery (SRS) Annual Meeting, where the company will showcase its LIBERTY® Endovascular Robotic System and contribute to discussions surrounding the expanding role of robotics in endovascular and neurovascular care.
The annual meeting is scheduled to take place from July 23 through July 26 in Fort Lauderdale, Florida. The event brings together surgeons, physicians, researchers, technology developers, healthcare professionals, and industry stakeholders to examine developments in robotic surgery and the growing application of digital technologies across medical specialties.
For Microbot Medical, participation in this year’s meeting represents an opportunity to highlight the progress of endovascular robotics and the growing interest in robotic-assisted solutions for minimally invasive procedures.
The company said the meeting is particularly significant because endovascular robotics was first featured at the SRS gathering only last year. Since then, the sector has continued to attract increasing attention as hospitals and academic medical centers explore technologies designed to support physicians performing complex vascular procedures.
Growing Role of Endovascular Robotics
Robotic surgery has traditionally been associated with procedures involving areas such as general surgery, urology, gynecology, and other specialties. However, robotic technologies are increasingly being explored for vascular and endovascular applications.
Endovascular procedures are performed through blood vessels and often involve the use of catheters, guidewires, and other specialized instruments. These procedures can be technically demanding and may require physicians to perform precise movements while navigating complex vascular anatomy.
Robotic systems are being developed to support physicians by providing advanced control and potentially improving procedural consistency.
Microbot Medical believes the growing focus on endovascular robotics reflects the increasing importance of the segment within the broader robotic surgery market.
The company’s LIBERTY Endovascular Robotic System is designed to support physicians during peripheral endovascular procedures.
The system is intended to provide robotic assistance while allowing clinicians to control the movement of endovascular devices remotely from a workstation.
The company believes that the technology may offer benefits related to physician ergonomics, procedural control, and workflow efficiency.
LIBERTY System Expands Its Clinical Presence
Microbot Medical received FDA clearance for the LIBERTY System less than a year before the upcoming SRS meeting.
Since receiving regulatory clearance, the company has focused on increasing adoption of the system among leading academic medical centers in the United States.
The company said the LIBERTY System is being adopted for a broad range of peripheral endovascular procedures.
Academic medical centers can play an important role in the adoption of emerging medical technologies. These institutions often participate in clinical research, physician education, technology evaluation, and the development of new treatment approaches.
The growing use of the LIBERTY System at these centers may provide Microbot Medical with opportunities to expand awareness of its technology among physicians and healthcare institutions.
The company believes that continued adoption can also support further clinical experience with robotic-assisted endovascular procedures.
Focus on Neurovascular Robotics
One of the key sessions at this year’s SRS Annual Meeting will focus on neurovascular robotics.
The panel, titled “Neurovascular Robotics,” is scheduled to take place at 9:50 a.m. Eastern Time on Saturday, July 25.
The session will be moderated by Dr. Adnan Siddiqui, a University of Buffalo Distinguished Professor and Vice Chairman in the Department of Neurosurgery at the State University of New York at Buffalo’s Jacobs School of Medicine and Biomedical Sciences.
The focus on neurovascular robotics highlights the broader interest in applying robotic technology to procedures involving the brain and vascular system.
Neurovascular interventions can involve highly precise catheter-based procedures and require physicians to navigate complex anatomy.
Although Microbot Medical’s LIBERTY System is focused on peripheral endovascular procedures, the company believes the broader discussion surrounding neurovascular robotics demonstrates the growing interest in robotic technologies across vascular medicine.
The inclusion of endovascular robotics at major robotic surgery meetings also reflects the evolution of the field.
As technology developers continue to advance robotic systems, the potential applications of robotics are expanding beyond traditional surgical procedures.
Supporting Physician Control and Procedural Precision
One of the key goals of endovascular robotic technology is to provide physicians with enhanced control over catheter-based procedures.
During traditional endovascular interventions, physicians may spend extended periods standing near imaging equipment and manually manipulating devices.
Robotic systems can provide an alternative method of controlling endovascular instruments.
The LIBERTY System is designed to enable physicians to control procedural tools from a dedicated workstation.
This approach may provide potential ergonomic benefits by allowing physicians to perform procedures while seated away from radiation sources.
The use of robotics may also support precise movements during procedures.
As endovascular procedures become increasingly complex, technology capable of supporting physician control may become more important.
Microbot Medical is seeking to establish the LIBERTY System as a solution for hospitals and physicians looking to incorporate robotic assistance into peripheral endovascular procedures.
Recognition for Innovation
Microbot Medical’s participation in the SRS Annual Meeting follows recent recognition from Surgical Robotics Technology.
The company was awarded the Innovative Start-Up Award by Surgical Robotics Technology.
The award recognizes companies demonstrating technological and commercial progress through innovative technologies with the potential to create broad healthcare impact.
Microbot Medical said the recognition further highlights the development of the LIBERTY System and the company’s progress in the endovascular robotics market.
Awards and industry recognition can help emerging medical technology companies increase awareness among investors, healthcare providers, physicians, and potential commercial partners.
For Microbot Medical, the recognition comes as the company continues to focus on expanding the commercial and clinical presence of its robotic technology.
A Changing Robotic Surgery Landscape
The development of endovascular robotics is occurring as the broader robotic surgery industry continues to evolve.
Healthcare providers are increasingly evaluating technologies that may help improve procedural efficiency, reduce physician fatigue, and support the delivery of minimally invasive care.
At the same time, medical technology companies are developing new robotic platforms for specialized applications.
The emergence of endovascular robotics adds another dimension to the market.
Unlike many traditional robotic surgery platforms, endovascular systems are designed for procedures performed through blood vessels.
This requires specialized technology capable of controlling small, flexible instruments and navigating complex anatomy.
As more companies develop technologies in this area, clinical evidence and physician experience will likely become increasingly important.
The long-term adoption of robotic endovascular systems may depend on factors such as clinical performance, ease of use, cost, workflow integration, and the ability to demonstrate value for hospitals and patients.
Importance of Academic Medical Centers
Microbot Medical’s reported adoption of the LIBERTY System at leading academic centers in the United States represents an important element of the company’s growth strategy.
Academic medical centers often serve as early adopters of innovative technologies.
They may also play a role in evaluating new procedures, developing clinical protocols, and training physicians.
The presence of robotic endovascular technology at these institutions may help create additional opportunities for clinical experience and physician education.
As physicians become more familiar with robotic-assisted procedures, adoption may potentially expand to additional hospitals and healthcare systems.
The company’s continued participation in professional meetings such as the SRS Annual Meeting provides an opportunity to engage with specialists who are evaluating the future of robotic surgery.
Expanding Awareness of Peripheral Endovascular Procedures
Peripheral endovascular procedures are used to diagnose and treat conditions affecting blood vessels outside the heart and brain.
These procedures can involve the treatment of vascular disease affecting the legs and other areas of the body.
As the global population ages and the prevalence of vascular disease increases, demand for minimally invasive treatment options continues to grow.
Robotic technologies may offer opportunities to support physicians performing these procedures.
Microbot Medical believes that the LIBERTY System can contribute to the development of robotic solutions for peripheral vascular interventions.
The company’s participation in the SRS meeting allows it to present the technology within a broader discussion of the future of robotic surgery.
The Importance of Industry Collaboration
The advancement of robotic surgery depends on collaboration among technology companies, physicians, researchers, hospitals, and professional organizations.
Meetings such as the SRS Annual Meeting provide a platform for these groups to share research, discuss clinical experience, and examine emerging technologies.
For companies developing new robotic systems, these events can provide valuable opportunities to engage directly with medical professionals.
They also allow healthcare providers to learn more about technologies that may influence future clinical practice.
Microbot Medical’s participation in the meeting reflects its interest in continuing to engage with the broader robotic surgery community.
The company believes that the increasing focus on endovascular and neurovascular robotics represents an important opportunity to advance minimally invasive care.
Microbot Medical’s presence at the Society of Robotic Surgery Annual Meeting comes at an important stage in the development of its LIBERTY Endovascular Robotic System.
With FDA clearance achieved less than a year ago and reported adoption at leading academic centers across the United States, the company is working to expand awareness and utilization of its technology.
The continued inclusion of endovascular robotics in the SRS program demonstrates the growing interest in robotic-assisted vascular procedures.
The upcoming “Neurovascular Robotics” panel will further highlight the potential of robotic technologies in complex catheter-based interventions.
Although the medical applications and technology requirements can vary across vascular specialties, the broader movement toward robotic assistance reflects continued innovation in minimally invasive medicine.
Microbot Medical is positioning the LIBERTY System within this expanding market by focusing on peripheral endovascular procedures and seeking to support physicians with robotic control technology.
The company’s recent Innovative Start-Up Award from Surgical Robotics Technology adds further recognition to its development efforts.
As healthcare providers continue evaluating new robotic technologies, Microbot Medical will likely focus on expanding clinical adoption, generating additional physician experience, and demonstrating the potential value of the LIBERTY System.
The company believes the future of robotic surgery will extend well beyond traditional operating room applications. With vascular and endovascular robotics gaining greater attention, Microbot Medical is seeking to establish a role in the continued transformation of minimally invasive care.
Its participation in the SRS Annual Meeting provides an opportunity to showcase the LIBERTY System, engage with experts in robotic surgery, and contribute to the ongoing discussion about how robotics and digital technologies may shape the future of vascular medicine.
Source link: https://ir.microbotmedical.com/
